{"version":"1.0","provider_url":"https:\/\/warpwire.duke.edu","provider_name":"Warpwire","is_public":true,"duration":3878,"has_caption":true,"links":{"caption":[{"label":"English","url":"https:\/\/warpwire.duke.edu\/api\/caption\/HdgIAA\/339911\/vtt\/?nonce=4f698bf7f0501a024fe53065b7d6643d&expiration=1790092800&signature=ca906b9d62ae4c206aa204d6367131c34b48c71c6ff85edf7e6dcb1083ab9bf8"}]},"views":9,"upload_date":"2025-05-08T17:03:07+00:00","author_name":"Tracey Koepke","html":"\u003Ciframe width=\"640\" height=\"360\" src=\"https:\/\/warpwire.duke.edu\/w\/HdgIAA\/\" frameborder=\"0\" allow=\"autoplay; encrypted-media; camera; microphone; picture-in-picture\" allowfullscreen\u003E\u003C\/iframe\u003E","height":360,"width":640,"thumbnail_height":360,"thumbnail_width":640,"url":"https:\/\/warpwire.duke.edu\/w\/HdgIAA\/","type":"video","title":"5\/6\/25: Getting to the heart of the matter: GLP-1 receptor agonists and CV disease with Darren K. McGuire, MD, MHSc, of UTSW and Parkland Health.","thumbnail_url":"https:\/\/warpwire.duke.edu\/img\/6ACA0562-AF10-4DC8-A013-9C6D868DE359\/355DB2FF-F0B0-4408-9F21-EAC1309633F2\/large\/"}